On Thursday, Ark Invest, led by Kathy Wood, made interesting trades, including the sale of 85,456 shares of Tesla from its ARK Innovation ETF and ARK Autonomous Technology & Robotics ETF. The sale totaled $22.22 million based on Tesla's closing price. This decision came after Tesla's impressive Q3 earnings report, which beat expectations and presented a positive outlook for vehicle deliveries through 2025. In addition to selling Tesla shares, Ark Invest's ARKG ETF sold shares of Vertex Pharmaceuticals Inc, while ARKG and ARKK ETFs acquired shares of CRISPR Therapeutics AG. Shares of Intellia Therapeutics Inc were purchased by ARKG and ARKK, and ARKG also added shares of Cerus Co.



Other News from Today